Skip to main content

Parallel Advisors, LLC

SEC CIK
0001690010
Latest filing
Aug 5, 2026

NVCR holding history

NovoCure Ltd in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVCR overviewAll 13F holders of NVCRFull Q2 2026 holdings

Shares (Q2 2026)
825
Value
$12.5K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NVCR by Parallel Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026825$12.5K<0.1%+585+243.8%AddedHolders
Q1 2026240$2.62K<0.1%+111+86.0%AddedHolders
Q4 2025129$1.67K<0.1%−296−69.6%ReducedHolders
Q3 2025425$5.49K<0.1%−1,169−73.3%ReducedHolders
Q2 20251,594$28.4K<0.1%−324−16.9%ReducedHolders
Q1 20251,918$34.2K<0.1%+100+5.5%AddedHolders
Q4 20241,818$54.2K<0.1%+27+1.5%AddedHolders
Q3 20241,791$28.0K<0.1%−72−3.9%ReducedHolders
Q2 20241,863$31.9K<0.1%+487+35.4%AddedHolders
Q1 20241,376$21.5K<0.1%+1,109+415.4%AddedHolders
Q4 2023267$3.99K<0.1%+28+11.7%AddedHolders
Q3 2023239$3.86K<0.1%+223+1,393.8%AddedHolders
Q2 202316$664<0.1%−148−90.2%ReducedHolders
Q1 2023164$9.86K<0.1%−346−67.8%ReducedHolders
Q4 2022510$37.4K<0.1%+24+4.9%AddedHolders
Q3 2022486$37.0K<0.1%−66−12.0%ReducedHolders
Q2 2022552$38.0K<0.1%−121−18.0%ReducedHolders
Q1 2022673$57.0K<0.1%+226+50.6%AddedHolders
Q4 2021447$34.0K<0.1%+294+192.2%AddedHolders
Q3 2021153$18.0K<0.1%−6−3.8%ReducedHolders
Q2 2021159$35.0K<0.1%+91+133.8%AddedHolders
Q1 202168$9.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.